,

Jing Yuan1,2,3, Na Xu1,2,3, Xueqi Gong1,2,3

  • 1Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

概括

这项研究确定PCLO是宫癌疫苗的一个有希望的目标. 特定的PCLO具有强烈的免疫原性,增强免疫细胞透和激活,以实现潜在的治疗突破.